Rafael Holdings
Holding Companies & Conglomerates · New Jersey, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
520 Broad St, Newark, New Jersey, 07102,...Phone Number
(212) 658-1450Website
www.rafaelholdings.comRevenue
<$5 MillionStock Symbol
RFLIndustry
ZI Rank: 3
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
2
2
3
3
2
3
About Rafael Holdings
Rafael Holdings, Inc. primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in two segments, Healthcare and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Its lead drug candidate is CPI-613 (devimistat), currently under Phase III clinical study for the treatment of metastatic pancreatic cancer and acute myeloid leukemia. The company is also involved in developing Promitil, a molecule designed for the targeted delivery of mitomycin-C in a proprietary prodrug form, completed Phase 1B clinical studies; Folate-targeted Promitil (Promi-Fol) which is aimed at local treatment (intravesical) of superficial bladder cancer; and Promi-Dox, a highly potent dual drug liposome with MLP and doxorubicin targeting a potential basket of tumors. In addition, it engages inRead more
Rafael Holdings Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Rafael Holdings your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Rafael Holdings
Rafael Holdings, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Click to see if Rafael Holdings had a recent Job posting/layoffs
Check out if Rafael Holdings is spiking on competitors!
Earning: See what the market has to say on Rafael Holdings recently announced quarterly report
Funding: Get notified immidiatlly once Rafael Holdings has new funding data
Product Launch: Get notified when Rafael Holdings launches new products
Check if Rafael Holdings has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Rafael Holdings
Find more new buyers
Compare Similar Companies to Rafael Holdings
Compare insights from companies similar to Rafael Holdings, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
1-10
Public
-
1982
MC
Michael CatelaniPresident & Chief Operating Officer & Chief Financial Officer
Company Profile Activity
Activity Insights
Rafael Holdings is experiencing very low activity levels compared to other companies in the Holding Companies & Conglomerates sector.
What does this means?
Rafael Holdings is drawing exceptional interest within the Holding Companies & Conglomerates industry, suggesting notable developments or strong market momentum, learn more about Rafael Holdings.
Rafael Holdings financials insights
Gather financial insights about Rafael Holdings, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$350K
Rafael Holdings Tech Stack
A closer look at the technologies used by Rafael Holdings
See more technologies
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
Left Company
Executive Move
Executive Moves, Left Company
New Hire
Executive Move
Executive Moves, New Hire, Board of Directors
Lateral Move
Executive Move
Executive Moves, Lateral Move
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Rafael Holdings News & Media
Rafael Holdings Announces Completion of Last Patient Last Visit for Pivotal Phase 3 TransportNPC™ Study Evaluating Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type C
Topline results are expected to be announced in second half of calendar 2026Rafael Holdings Announces Patent Licensing Agreement with MIT for “Small Molecules to Improve Myelination in ApoE4 positive Alzheimer’s Disease”
License of the MIT patent strengthens Rafael’s intellectual property around cyclodextrins as an Active Pharmaceutical Ingredient (API) in the treatment of ApoE4-positive Alzheimer’s Disease License of the MIT patent strengthens Rafael’s intellectual property around cyclodextrins as an Active Pharmaceutical Ingredient (API) in the treatment of ApoE4-positive Alzheimer’s DiseaseRafael Holdings Reports Second Quarter Fiscal 2026 Financial Results
NEWARK, N.J., March 16, 2026 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL) today reported its financial results for the second quarter fiscal year 2026 ended January 31, 2026.Rafael Holdings Reports First Quarter Fiscal 2026 Financial Results
NEWARK, N.J., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL) today reported its financial results for the first quarter fiscal year 2026 ended October 31, 2025.
Read more news
Top Holding Companies & Conglomerates Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Rafael Holdings
Sign Up For FreeTo access detailed company insights
Rafael Holdings, Inc. primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in two segments, Healthcare and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic difference... Read More
